Drug Response Profiling Informs Personalized Bridging to Cell Therapy for Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaFabio D. Steffen, Jean‐Pierre Bourquin, Julia Alten et al.|Blood|2023Cited by 1